USPTO serial 79412638
IASO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 12, 2026
- Examiner
- RATCLIFFE, ROBERT L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IASO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Nanjing IASO Biotechnology Co., Ltd.
CN
Other trademarks owned by Nanjing IASO Biotechnology Co., Ltd.
Nanjing IASO Biotechnology Co., Ltd.
CN
Other trademarks owned by Nanjing IASO Biotechnology Co., Ltd.
Nanjing IASO Biotechnology Co., Ltd.
CN
Other trademarks owned by Nanjing IASO Biotechnology Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Yue Robert Xu
Yue Robert Xu Apex Attorneys at Law, LLP160 Alamo Plaza #942Alamo, CA 94507United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for the treatment of cardiovascular and cerebrovascular diseases; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for use in chemotherapy; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; biological preparations for the treatment of tumor; biological preparations for medical purposes, for the treatment of tumor, endocrine, metabolic, central nervous system disorders, autoimmune disorders and blood disorders; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biochemical preparations for medical purposes, for the treatment of tumor, endocrine, metabolic, central nervous system disorders, autoimmune disorders and blood disorders; reagents for use in medical genetic testing; pharmaceutical products for the prevention and treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; medical diagnostic reagents; anti-cancer preparations; pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; cytostatics for medical purposes; cells for medical use; antivirals; pharmaceutical preparations for the treatment of immune system related diseases and disorders; yeast extracts for medical, veterinary or pharmaceutical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nanjing IASO Biotechnology Co., Ltd.
- Other trademarks owned by Nanjing IASO Biotechnology Co., Ltd.
- Other trademarks owned by Nanjing IASO Biotechnology Co., Ltd.
- Other trademarks in Class 005
- Similar marks named IASO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 23, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 22, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 12, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 4, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 18, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 18, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 12, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 12, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 16, 2026 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Oct 16, 2025 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 7, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 7, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 1, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 5, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 16, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 16, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 16, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 5, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 17, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 17, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 16, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 15, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 3, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 3, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 31, 2024 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 19, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |